Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million ...Middle East

Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol) Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care's commercial platform to grow Movantik volume in the U.S. while reducing gross-to-net...

Hence then, the article about valinor pharma announces acquisition by grunenthal with a total deal value of approximately 250 million was published today ( Monday 22/07/2024 - 08:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million )

Also on site :

• 36 Years Ago Today, Stevie Ray Vaughan’s Final Concert Ended in an All-Star Jam—Then a Helicopter Crash Changed Everything
• ‘I’m a Hepatologist, and This Is the One Thing I Tell Every Patient With Fatty Liver To Start Eating’
• ‘Coyote vs. Acme’ Cast and Crew Held a ‘Funeral Screening’ After the Movie Was Shelved: ‘Was Emotional in So Many Ways’